TFAH Calls for Stockpiling of Masks to Meet Medical Requirements to Prepare for the Threat of Pandemic Flu
WASHINGTON, D.C. The Trust for America's Health (TFAH) says supports the interim guidance issued today by the Centers for Disease Control and Prevention (CDC) concerning standards for use of masks and respirators in the event of a pandemic flu outbreak. Masks and N95 respirator masks are important elements of a multi-pronged approach to containing a potential pandemic that also includes use of vaccines, antiviral medication, and hygiene. TFAH points out, however, that the U.S. stockpile of masks and respirators falls far short of the amounts that would be required to meet the levels needed for recommended use.
TFAH says that to reach recommended levels of capacity, especially for N95 respirator masks, production would have to be significantly increased. Funds must be directed to producing, purchasing and stockpiling the equipment.
"We shouldn't gamble with the health of Americans. The medical experts say we should be stockpiling masks and N95 respirators to protect our healthcare workers and to prevent the spread of a pandemic virus," said Jeff Levi, PhD, executive director of TFAH. "Just as the country has made an investment to increase production capacity and stockpiles of vaccines and anti-virals, we must do the same for respirators and masks."
TFAH also notes special attention must be paid to protecting children, as currently produced N-95 respirator masks are not manufactured to protect children. TFAH notes that the CDC has pointed out that children can be more susceptible than adults to infection, and compared to adults, children usually shed more influenza virus and for a longer period of time.
Source: Trust for America's Health
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
